Literature DB >> 7081986

Microbial transformations of warfarin: stereoselective reduction by Nocardia corallina and Arthrobacter species.

P J Davis, J D Rizzo.   

Abstract

The microbiological metabolism of warfarin was examined as a model of metabolism in higher organisms, including humans, and to determine the chirality of microbial reductases for application in organic synthesis. Nineteen cultures were examined based on their reported abilities to reduce ketonic substrates, and several were shown to catalyze the desired reaction. Nocardia corallina (ATCC 19070) exhibited complete substrate and product stereoselectivity as it reduced S-warfarin to the corresponding S-alcohol. Arthrobacter species (ATCC 19140) exhibited marked substrate and complete product stereoselectivity since S-warfarin, and to a lesser extent R-warfarin, were reduced to the corresponding S-alcohols. These reductions parallel those reported to occur in mammalian species.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7081986      PMCID: PMC241936          DOI: 10.1128/aem.43.4.884-890.1982

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  21 in total

1.  Warfarin-stereochemical aspects of its metabolism by rat liver microsomes.

Authors:  L R Pohl; S D Nelson; W R Porter; W F Trager; M J Fasco; F D Baker; J W Fenton
Journal:  Biochem Pharmacol       Date:  1976-10-01       Impact factor: 5.858

2.  Cumene hydroperoxide-supported microsomal hydroxylations of warfarin--a probe of cytochrome P-450 multiplicity and specificity.

Authors:  M J Fasco; L J Piper; L S Kaminsky
Journal:  Biochem Pharmacol       Date:  1979       Impact factor: 5.858

3.  Absolute configurations of the four warfarin alcohols.

Authors:  K K Chan; R J Lewis; W F Trager
Journal:  J Med Chem       Date:  1972-12       Impact factor: 7.446

4.  Mass spectral analysis in the identification of human metabolites of warfarin.

Authors:  W F Trager; R J Lewis; W A Garland
Journal:  J Med Chem       Date:  1970-11       Impact factor: 7.446

5.  Regioselective and stereoselective hydroxylation of R and S warfarin by different forms of purified cytochrome P-450 from rabbit liver.

Authors:  M J Fasco; K P Vatsis; L S Kaminsky; M J Coon
Journal:  J Biol Chem       Date:  1978-11-10       Impact factor: 5.157

6.  Microbial models of mammalian metabolism. Aromatic hydroxylation.

Authors:  R V Smith; J P Rosazza
Journal:  Arch Biochem Biophys       Date:  1974-04-02       Impact factor: 4.013

7.  Plasma half-lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man.

Authors:  D S Hewick; J McEwen
Journal:  J Pharm Pharmacol       Date:  1973-06       Impact factor: 3.765

8.  A new warfarin metabolite: structure and function.

Authors:  M J Fasco; P P Dymerski; J D Wos; L S Kaminsky
Journal:  J Med Chem       Date:  1978-10       Impact factor: 7.446

9.  Warfarin metabolism in man: identification of metabolites in urine.

Authors:  R J Lewis; W F Trager
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

10.  Microbial transformation of N-methylcolchiceinamide.

Authors:  P J Davis
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

View more
  4 in total

1.  Microbial models of mammalian metabolism: microbial reduction and oxidation of pentoxifylline.

Authors:  P J Davis; S K Yang; R V Smith
Journal:  Appl Environ Microbiol       Date:  1984-08       Impact factor: 4.792

2.  Microbial models of mammalian metabolism: stereoselective metabolism of warfarin in the fungus Cunninghamella elegans.

Authors:  Y W Wong; P J Davis
Journal:  Pharm Res       Date:  1989-11       Impact factor: 4.200

3.  The screening of selected microorganisms for use as models of mammalian drug metabolism.

Authors:  D A Griffiths; D J Best; S G Jezequel
Journal:  Appl Microbiol Biotechnol       Date:  1991-06       Impact factor: 4.813

Review 4.  Enantiospecific analysis: applications in bioanalysis and metabolism.

Authors:  A J Hutt; M R Hadley; S C Tan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jul-Sep       Impact factor: 2.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.